Skip to content

Drug interactions

Dapagliflozin + Insulin degludec

Severity: Moderate

Dapagliflozin and Insulin degludec: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dapagliflozin with insulin increases glucose lowering and the risk of hypoglycemia. SGLT2 inhibitors also carry a risk of ketoacidosis, which matters when insulin is reduced.

What this interaction means in plain words

Dapagliflozin and Insulin degludec can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dapagliflozin belongs to Endocrine; Insulin degludec belongs to Endocrine.

Evidence level: High

Why it happens

SGLT2 inhibition increases urinary glucose excretion independent of insulin, adding to the effect of exogenous insulin.

What to do

Monitor blood glucose and consider a lower insulin dose when starting dapagliflozin, avoiding excessive reduction. Check ketones if symptoms of ketoacidosis occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dapagliflozin and Insulin degludec, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dapagliflozin with Insulin degludec?

MediHelp rates the interaction as moderate. Dapagliflozin and Insulin degludec can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dapagliflozin with insulin increases glucose lowering and the risk of hypoglycemia. SGLT2 inhibitors also carry a risk of ketoacidosis, which matters when insulin is reduced.

How serious is the interaction between Dapagliflozin and Insulin degludec?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and consider a lower insulin dose when starting dapagliflozin, avoiding excessive reduction. Check ketones if symptoms of ketoacidosis occur.

What other medicines interact with Insulin degludec?

MediHelp also lists interactions of Insulin degludec with, for example, Alogliptin-pioglitazone, Ethanol, Glimepiride-pioglitazone. The full list is on the Insulin degludec page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in